Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
J Rheumatol 2019; doi: 10.3899/jrheum.180718 Recently, the sponsor became aware of data errors related to Bath Ankylosing Spondylitis Metrology Index (BASMI) and the University of California San Francisco (UCSF) Enthesitis Index. The ensuing tabular and in-text corrections are provided hereinafter.
Authors
- Paul H. Caldron (ORCID: https://orcid.org/0000-0001-5222-1874)
- Lilianne Kim
- Anna Dudek (ORCID: https://orcid.org/0000-0003-1461-6271)
- John D. Reveille (ORCID: https://orcid.org/0000-0001-5950-0913)
- Jocelyn H. Leu (ORCID: https://orcid.org/0000-0002-8627-6512)
- Kim Hung Lo
- Diane D. Harrison
- Atul Deodhar
- Elizabeth C. Hsia
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3899/jrheum.180718.c1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00